Make your one-time, tribute, or recurring online gift to support brain tumour patient programs and research today: Donate
Hope is obtained everyday with new advances in research in the neuro-oncology field in Canada. Over time research has led to: improvements to technologies allowing us to view the brain; advances in surgical techniques, radiation practices and treatments for all tumour grades; as well as improvements for pediatric patients. The entire research program is funded thanks to generous donors from across Canada.
Since 1985, donor support has led to Brain Tumour Foundation of Canada dedicating more than $5.8 million to finding a cure for the disease and improving treatment for brain tumour survivors.
One researcher explains the impact of receiving research funding:
"Funding from Brain Tumour Foundation of Canada provided the necessary seed money to test novel ideas associated with my pediatric brain tumour work during my first year as a principal investigator. This grant also provided funds for a new graduate student in my laboratory. As a new investigator in Canada during a time when every dollar counts, support from Brain Tumour Foundation of Canada helps to ensure I have all the necessary resources to move my research forward and find new therapeutic targets for this highly aggressive disease."
Research is a fundamental component of our organization's mission to help patients. Watch this video to learn about the projects and research initiatives happening all the time - and made possible by the financial support from people like you.
Research Program Specialist
1-800-265-5106 ext. 240
We are celebrating bringing hope for 35 years! One of the ways we are marking this important milestone and sharing hope for the future, is with this video, where Steve Northey, one of our Founders, talks about why this organization started and how far we have come!Learn more
The best Christmas gift I could get would be to get this lump of coal out of my head. However, I do have good days. And recently, a lot...Learn more
Stephen was diagnosed with an anaplastic oligodendroglioma (grade III) in November of 2015 at the age of 53 years old, and shares his...Learn more